Form 4 filed by Kelly Thomas Patrick
Kelly Thomas Patrick filed this Form 4 on XENE (Xenon Pharmaceuticals Inc.) with 2 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-17 00:22:19 UTC.
- Accession
- 0001193125-26-424428
- Filer
- CIK 1410514
- Filed
- 2026-10-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: XENE · Xenon Pharmaceuticals Inc. (CIK 1582313)
- Kelly Thomas Patrick officer (Chief Financial Officer)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Shares | 2026-10-15 | M exercised | +7,500 | 22,500 | D | |
| Restricted Share Units derivative | 2026-10-15 | M exercised | -7,500 | $0 | 22,500 | D |